BlackRock, Inc. 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
83,037 1.100% |
-398,690 (-82.76%) |
Filing |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
481,727 6.600% |
58,635 (+13.86%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
423,091 6.200% |
135,967 (+47.35%) |
Filing |
| 2022-05-09 3:23 pm Purchase |
2022-04-30 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
287,124 4.800% |
18,422 (+6.86%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
268,702 5.500% |
16,793 (+6.67%) |
Filing |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
BLACKROCK INC BLK |
251,909 5.400% |
251,909 (New Position) |
Filing |